MedTrace Logo

Assessing Closed-loop Insulin Delivery in Children With Type 1 Diabetes.

NCT04612257 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2023-07-12

No results posted yet for this study

Summary

The objective of this clinical trial is to assess the safety of our insulin dosing algorithm in children with type 1 diabetes in a free-living study.

Conditions

  • Diabetes Mellitus, Type 1

Interventions

OTHER

Insulin-alone closed-loop

40-hour intervention period using the insulin-alone closed-loop system.

Sponsors & Collaborators

Principal Investigators

  • Laurent Legault, MD · Montreal Children's Hospital of the MUHC

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
2 Years
Max Age
13 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-18
Primary Completion
2022-06-13
Completion
2022-06-13

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04612257 on ClinicalTrials.gov